Results 191 to 200 of about 39,378 (264)

Surgical, Histopathological, and Quality of Life Outcomes Following Neoadjuvant Chemotherapy and Pancreatectomy for Borderline Resectable and Locally Advanced Pancreatic Cancer. [PDF]

Cancers (Basel)
Farnes I, Verbeke CS, Kleive D, Waage A, Tholfsen T, Hagen M, Fosby B, Line PD, Labori KJ.   +8 more
europepmc   +1 more source

Outcomes of Liver Transplant Versus Partial Hepatectomy for Perihilar Cholangiocarcinoma Patients Requiring Arterial Reconstruction

Liver International, Volume 46, Issue 7, July 2026.
ABSTRACT Background and Aims Liver resection (LR) and orthotopic liver transplantation (OLT) are therapeutic options for locally advanced perihilar cholangiocarcinoma (pCCA) requiring hepatic artery reconstruction (HAR). This study aimed to compare short‐ and long‐term outcomes of LR and OLT. Outcomes were major vascular complications, 90‐day mortality,
Edoardo Poletto, Pim B. Olthof, Andrea Ruzzenente, Jean‐Philippe Adam, Ian P. J. Alwayn, Emmanuel Boleslawski, Marieke T. de Boer, Alexandre Chebaro, Laurence Chiche, Cristina Dopazo, Jeroen Dubbeld, Joris I. Erdmann, Abdul Hakeem, Minneke J. Coenraad, Hendrien Kuipers, Jean‐Yves Mabrut, Charlotte Maulat, Shishir K. Maithel, Vincent E. de Meijer, Kayvan Mohkam, Sarwa Darwish Murad, Fabrice Muscari, Jens Rolinger, Wojciech G. Polak, Michel Rayar, Francesca Ratti, Fabien Robin, Andreas A. Schnitzbauer, Ernesto Sparrelid, Frederike G. I. Van Vilsteren, Robert J. Porte, Frederik J. H. Hoogwater, Bas Groot Koerkamp, on behalf of the Perihilar Cholangiocarcinoma Collaboration Group, L. Aldrighetti, W. O. Bechstein, M. A. de Boer, S. Büttner, I. Capobianco, R. Charco, L. C. Franken, S. Gilg, C. Gomez‐Gavara, A. Guglielmi, T. M. van Gulik, J. Heil, H. Jansson, G. Kazemier, P. Lodge, R. Marino, S. Nadalin, T. A. Nguyen, R. Prasad   +52 more
wiley   +1 more source

Inflammatory Biomarkers Predict Local Control and Survival After Escalated High-Dose SBRT in Borderline and Locally Advanced Pancreatic Cancer. [PDF]

J Clin Med
Ferrera-Alayon L, Alayón Afonso A, Salas-Salas B, Rodríguez-González N, Lara PC, Lloret-Saez-Bravo M.   +5 more
europepmc   +1 more source

Locally advanced metastatic pancreatic cancer

, 2021
openaire   +1 more source

Efficacy of a structured rehabilitation program for patients with terminal cancer: A multicenter randomized controlled trial

Cancer, Volume 132, Issue 12, 15 June 2026.
Abstract Background Maintaining activities of daily living is of great importance for patients who have cancer, and dependency is associated with psychological distress. However, evidence for rehabilitation remains scarce in this setting. The objective of this study was to evaluate the efficacy of a structured rehabilitation program for maintaining ...
Nanako Nishiyama, Yoshinobu Matsuda, Noriko Fujiwara, Keiichi Narita, Shunsuke Oyamada, Keisuke Ariyoshi, Yukiko Hosono, Kazuaki Kushi, Katsuaki Ichimaru, Ritsuko Yabuki, Keisuke Kaneishi, Kiriko Abe, Takahiro Fujihara, Yoshihito Kono, Kozue Suzuki, Tae Kinoshita, Takeshi Sasara, Masato Nakajima, Hironori Mawatari, Hiroki Sugawara, Kentaro Nobutani, Yuriko Shindoh, Koichiro Kobayashi, Takashi Yamaguchi, Ryuji Iwaki, Yosuke Kitazoe, Yoshiaki Kanai, Junya Ueno, Tesshin Fukumi, Ryouhei Ishii, Nobuhisa Nakajima   +30 more
wiley   +1 more source

Redirecting venous flow from the superior mesenteric vein to the inferior mesenteric vein in resections for locally advanced pancreatic cancer. [PDF]

Langenbecks Arch Surg
Burgdorf SK, Pai M, Habib NH, Storkholm JH.   +3 more
europepmc   +1 more source

Efficacy and immunogenic effects of Tumor Treating Fields (TTFields) in preclinical models of pancreatic ductal adenocarcinoma, with and without gemcitabine/nab‐paclitaxel

International Journal of Cancer, Volume 158, Issue 12, Page 3091-3100, 15 June 2026.
What's new? Adaptive immune responses are typically limited in pancreatic ductal adenocarcinoma, resulting in minimal efficacy of immune checkpoint inhibitors. Tumor Treating Fields (TTFields) therapy, which uses low‐intensity intermediate‐frequency electric fields to disrupt cancer cell processes, has been approved for certain cancers.
Tal Kan, Tharwat Haj Khalil, Yiftah Barsheshet, Tali Voloshin, Lilach Koren, Bella Koltun, Cfir David, Kerem Wainer‐Katsir, Avital Vorontsova, Boris Brant, Simona Zisman‐Rozen, Hila M. Ene, Roni Frechtel‐Gerzi, Shay Cahal, Anat Klein‐Goldberg, Lena Lifshitz, Efrat Zemer Tov, Mai Shai, Adi Haber, Moshe Giladi, Uri Weinberg, Yoram Palti   +21 more
wiley   +1 more source

First Spanish Experience with Stereotactic MR-Guided Adaptive Radiotherapy (SMART) in Borderline Resectable and Locally Advanced Pancreatic Cancer: A Prospective Study. [PDF]

Biomedicines
Gonsalves D, Ocanto A, Meilan E, Gomez A, Dominguez J, Torres L, Fernández C, Teja M, Garrido I, Gonzalez M, Gaztañaga M, Herrero D, Thuissard IJ, Andreu C, Gonzalez T, González JA, Yagüe JA, Holgado E, Alcaraz D, López E, Dzhugashbli M, Glaria L, Lopez-Campos F, Dominguez E, Rodriguez Pascual J, Martin EML, Sanz-Rosa D, Chuong MD, Riou O, Couñago F.   +29 more
europepmc   +1 more source

Ultrasmall Platinum Nanoparticles for Radiation‐Enhanced Cancer Therapy

Advanced Functional Materials, Volume 36, Issue 45, 5 June 2026.
This work proposes a nanomedicine‐based strategy to enhance X‐ray radiotherapy for cancer treatment. Ultrasmall Pt‐NPs exhibit catalase‐like activity that may contribute to modulation of the tumor microenvironment and amplify interactions between radiation and biological matter, leading to increased DNA damage.
Miguel Encinas‐Gimenez, Jose I. Garcia‐Peiro, Jose L. Hueso, Eduardo Caleiras, Laura Notario, Felipe Hornos, Pilar Martin‐Duque, Antonio De la Vieja, Jesus Santamaria   +8 more
wiley   +1 more source

Exploring Endovascular Photo-Activated Ablation (EPA) for Downstaging Locally Advanced Pancreatic Cancer: A Proof-of-Concept Study in the Normal Porcine Model. [PDF]

Cancers (Basel)
García Vázquez A, Verde JM, Wanert F, Spiridon IA, Schmid A, Saeidi T, Swanstrom LL, Bown SG, Lilge L, Bogaards A.   +9 more
europepmc   +1 more source